Literature DB >> 16470593

Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease.

Marc Dhenain1, Benoît Delatour, Christine Walczak, Andreas Volk.   

Abstract

Amyloid plaques are one of the hallmarks of Alzheimer's disease (AD). This study evaluated a novel microMRI strategy based on "passive staining" of brain samples by gadoteric acid. The protocol was tested at 4.7 T on control animals and APP/PS1 mice modeling AD lesions. T(1) was strongly decreased in passively stained brains. On high-resolution 3D gradient echo images, the contrast between the cortex and subcortical structures was highly improved due to a T2* effect. The brains of APP/PS1 mice revealed plaques as hypo-intense spots. They appeared larger in long compared to short TE images. This suggests that, after passive staining, plaques caused a susceptibility effect. This easily performed protocol is a complementary method to classic histology to detect the 3D location of plaques. It may also be used for the validation of in vivo MRI protocols for plaque detection by facilitating registration with histology via post mortem MRI. Magn Reson Med, 2006. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16470593     DOI: 10.1002/mrm.20810

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  13 in total

1.  Models of neurodegenerative disease - Alzheimer's anatomical and amyloid plaque imaging.

Authors:  Alexandra Petiet; Benoit Delatour; Marc Dhenain
Journal:  Methods Mol Biol       Date:  2011

2.  In vivo magnetic resonance imaging of amyloid-β plaques in mice.

Authors:  Youssef Zaim Wadghiri; Dung Minh Hoang; Thomas Wisniewski; Einar M Sigurdsson
Journal:  Methods Mol Biol       Date:  2012

3.  SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.

Authors:  Laurel O Sillerud; Nathan O Solberg; Ryan Chamberlain; Robert A Orlando; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; David L Vander Jagt
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

4.  In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through?

Authors:  Benoît Delatour; Stéphane Epelbaum; Alexandra Petiet; Marc Dhenain
Journal:  Int J Alzheimers Dis       Date:  2010-09-30

5.  Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease.

Authors:  Fernando Goñi; Frances Prelli; Yong Ji; Henrieta Scholtzova; Jing Yang; Yanjie Sun; Feng-Xia Liang; Regina Kascsak; Richard Kascsak; Pankaj Mehta; Thomas Wisniewski
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

6.  Immunomodulation targeting of both Aβ and tau pathological conformers ameliorates Alzheimer's disease pathology in TgSwDI and 3xTg mouse models.

Authors:  Fernando Goñi; Krystal Herline; Daniel Peyser; Kinlung Wong; Yong Ji; Yanjie Sun; Pankaj Mehta; Thomas Wisniewski
Journal:  J Neuroinflammation       Date:  2013-12-13       Impact factor: 8.322

7.  Broad Influence of Mutant Ataxin-3 on the Proteome of the Adult Brain, Young Neurons, and Axons Reveals Central Molecular Processes and Biomarkers in SCA3/MJD Using Knock-In Mouse Model.

Authors:  Kalina Wiatr; Łukasz Marczak; Jean-Baptiste Pérot; Emmanuel Brouillet; Julien Flament; Maciej Figiel
Journal:  Front Mol Neurosci       Date:  2021-06-17       Impact factor: 5.639

8.  Micro-MRI study of cerebral aging: ex vivo detection of hippocampal subfield reorganization, microhemorrhages and amyloid plaques in mouse lemur primates.

Authors:  Anne Bertrand; Adrien Pasquier; Alexandra Petiet; Christopher Wiggins; Audrey Kraska; Nelly Joseph-Mathurin; Fabienne Aujard; Nadine Mestre-Francés; Marc Dhenain
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

9.  Structural layers of ex vivo rat hippocampus at 7T MRI.

Authors:  Jeanine Manuella Kamsu; Jean-Marc Constans; Franck Lamberton; Patrick Courtheoux; Pierre Denise; Bruno Philoxene; Maelle Coquemont; Stephane Besnard
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

10.  In Vivo Detection of Amyloid Plaques by Gadolinium-Stained MRI Can Be Used to Demonstrate the Efficacy of an Anti-amyloid Immunotherapy.

Authors:  Mathieu D Santin; Michel E Vandenberghe; Anne-Sophie Herard; Laurent Pradier; Caroline Cohen; Thomas Debeir; Thierry Delzescaux; Thomas Rooney; Marc Dhenain
Journal:  Front Aging Neurosci       Date:  2016-03-22       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.